U.S., Jan. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07316465) titled 'Birth Cohort: Development of IgE Autoantibodies in Newborns With (High Risk of) Atopic Dermatitis' on Nov. 21, 2025.
Brief Summary: Previous research has shown that some patients with atopic eczema have specific self-reactive antibodies, known as IgE autoantibodies, that react to their own skin cells, referred to as "self-reactive antibodies" or "autoantibodies". It is not yet known when and how these self-reactive antibodies develop, so this is what we aim to investigate.
This study aims to examine the presence of self-reactive antibodies at birth. In other words, the investigators want to study the earliest stage of developing ant...